Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001587487-25-000004
Filing Date
2025-12-29
Accepted
2025-12-29 17:05:53
Documents
2
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 form4-12292025_101249.html 4  
1 form4-12292025_101249.xml 4 4029
2 ex24-12292025_101249.htm EX-24 6957
  Complete submission text file 0001587487-25-000004.txt   12468
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Wigginton Jon Marc (Reporting) CIK: 0001587487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 251610013